Probiotic is useful for ulcerative colitisBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7499.0-f (Published 05 May 2005) Cite this as: BMJ 2005;330:0-f
Question In patients with ulcerative colitis currently in remission, is the probiotic Escherichia coli Nissle 1917 as effective as standard treatment to prevent relapse?
Synopsis Probiotics are live, but non-pathogenic, micro-organisms that are used to alter the microbial balance in the intestinal tract. Although most probiotics are Gram positive species (Lactobacillus spp), E coli Nissle 1917 (EcN) is a Gram negative probiotic of a different strain than toxic E coli;it may work by causing an immune response or preventing invasion of other bacteria. The investigators …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial